Pharmacovigilance and Drug Safety Software Market Trends
The global pharmacovigilance
and drug safety software market is poised to grow at a CAGR of 6.5% during
2014-2019, and is expected to reach a value of $154.1 Million in 2019.
In this report, the global pharmacovigilance and drug safety
software market has been classified into many segments on the basis of
functionality, namely, adverse event reporting software, drug safety audits
software, issue tracking software, and fully integrated software. The global
pharmacovigilance and drug safety software market is divided into two segments
on the basis of delivery mode, namely, on-premise delivery mode and
on-demand/cloud based (SaaS) delivery mode. The global pharmacovigilance and
drug safety software market is also segmented on the basis of end users
including pharma and biotech companies, contract research organizations (CROs),
business process outsourcing (BPO) firms, and other pharmacovigilance service
providers.
ArisGlobal (U.S.), Ennov Solutions Inc. (U.S.), EXTEDO GmbH
(U.S.), Online Business Applications, Inc. (U.S.), Oracle Corporation (U.S.),
Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (U.S.), and United
BioSource Corporation (U.S.) are some of the key players in the global
pharmacovigilance and drug safety software market.
As of 2014, North America holds the largest share of the global
pharmacovigilance and drug safety software market, followed by Europe. However,
Asian and Latin American countries represent high growth markets, owing to a
rise in research outsourcing by pharmaceutical giants and growing public and
private investments in pharmaceutical R&D in these emerging nations.
Comments
Post a Comment